Loading insider details...
Beta
Latest Form 4 (Sep 2, 2026): Tax Withholding of 14 JAZZ shares, $3.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Tax Withholding | 14 | $3.4K |
| Aug 7, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Grant/Award | 1,605 | n/a |
| Jun 15, 2026 | FATE THERAPEUTICS INC (FATE) | Grant/Award | 175,800 | n/a |
| Aug 11, 2025 | Jazz Pharmaceuticals plc (JAZZ) | Grant/Award | 3,507 | n/a |
| Aug 6, 2024 | Jazz Pharmaceuticals plc (JAZZ) | Grant/Award | 3,731 | n/a |
| Jun 13, 2024 | Y-mAbs Therapeutics, Inc. (YMAB) | Grant/Award | 3,495 | n/a |
| Jan 17, 2023 | Scilex Holding Co (SCLX) | Grant/Award | 250,000 | n/a |
| Jan 11, 2023 | ANAPTYSBIO, INC (ANAB) | Grant/Award | 10,600 | n/a |
| Feb 14, 2022 | ANAPTYSBIO, INC (ANAB) | Grant/Award | 9,200 | n/a |
| Feb 13, 2021 | ANAPTYSBIO, INC (ANAB) | Grant/Award | 11,000 | n/a |